Last reviewed · How we verify
Theophylline Powder
At a glance
| Generic name | Theophylline Powder |
|---|---|
| Also known as | Theophylline nasal irrigation, Low-dose Theophylline, Theophylline elixir |
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Smell in Covid-19 and Efficacy of Nasal Theophylline (PHASE2)
- A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication (PHASE3)
- A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Theophylline Powder CI brief — competitive landscape report
- Theophylline Powder updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI